secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOADAPTIVES, INC. (BDPT)
CIK:        0001575142
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0001640334-25-000428
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAdaptives' Zeranovia weight loss product shows 5-7 lbs/week loss in dosage trial
--------------------------------------------------------------------------------

- Participants lost 5–7 pounds per week in Zeranovia dosage trial.
- Minimal side effects: mild GI discomfort manageable by increasing water intake or adjusting dosage.
- All trial subjects requested to proceed to next phase, indicating high satisfaction.
- Company advancing to dosage adjustments for next-stage clinical trials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1575142/000164033425000428/0001640334-25-000428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1575142/000164033425000428/bdpt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-000428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer